Market Overview –
The Glaucoma Surgery Market encompasses surgical procedures and devices used to treat glaucoma, a group of eye conditions characterized by damage to the optic nerve, often caused by increased intraocular pressure. Glaucoma surgery aims to reduce intraocular pressure and prevent further vision loss by improving fluid drainage from the eye or decreasing fluid production.
In recent years, the glaucoma surgery market has witnessed significant growth globally due to several factors. Firstly, there has been increasing prevalence of glaucoma worldwide, attributed to aging populations and rising incidence of risk factors such as diabetes and hypertension. Key players in this market include medical device manufacturers, ophthalmic clinics, and healthcare providers specializing in glaucoma management, collaborating to develop and commercialize innovative surgical techniques and devices.
Moreover, advancements in surgical technology have led to the development of minimally invasive glaucoma surgeries (MIGS), offering safer and more effective alternatives to traditional glaucoma surgeries such as trabeculectomy and tube shunt procedures. MIGS procedures are associated with faster recovery times, fewer complications, and reduced reliance on topical medications, making them increasingly popular among patients and ophthalmologists.
The Glaucoma Surgery Market, also referred to as surgical glaucoma, is witnessing significant growth due to the rising prevalence of glaucoma and advancements in surgical techniques. Surgical interventions such as trabeculectomy and minimally invasive glaucoma surgery (MIGS) are increasingly preferred options for managing the condition, driving market expansion.
The Glaucoma Surgery Market Size was assessed at USD 0.6 billion in 2022 and is expected to rise from USD 0.63 billion in 2023 to USD 1.3 billion by 2032, with a compound annual growth rate (CAGR) of 6.7% during the forecast period (2023-2032).
Segmental Analysis
The segmental investigation into the glaucoma surgery market is conducted on the basis of target, surgery type, region, and end-user. On the basis of target, the glaucoma surgery market is segmented into suprachoroidal space, trabecular meshwork, and others. Based on the regions, the glaucoma surgery market is segmented into Asia Pacific, Middle East, North America, Europe, and Africa. Based on the type of surgery, the glaucoma surgery market is segmented into aqueous shunt surgery, laser surgery, angle-closure glaucoma surgery, and others. On the basis of end-users, the glaucoma surgery market is segmented into ambulatory surgery centers, hospitals, and others.
Detailed Regional Analysis
The regional assessment of the glaucoma surgery market is segmented into regions such as Asia Pacific, Middle East, North America, Europe, and Africa. The North American glaucoma surgery market orders the principal market for glaucoma surgery owing to a massive population experiencing diabetes and eye diseases. The growing healthcare spending and enhanced infrastructure have a positive influence on the progress of the glaucoma surgery market. The European region is the next prime market, trailed by the Asia Pacific glaucoma surgery market. A massive population center and speedy progress in the healthcare segment have appealed to numerous companies to progress the glaucoma surgery market in the Asia Pacific region.
Key Players –
Glaucoma Surgery companies include Abbott Laboratories Inc, Carl Zeiss Meditec, Ziemer Ophthalmic Systems, ASICO, LLC, Lumenis, Allergan, Alcon, Katalyst Surgical LLC, Glaukos Corporation, among others.
Related Reports –
population health management market
For more information visit at MarketResearchFuture
